| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2012/837375 |
| P8608 | Fatcat ID | release_lz6xmzje4feq7jct4sr4k5ntfu |
| P932 | PMC publication ID | 3350984 |
| P698 | PubMed publication ID | 22619487 |
| P5875 | ResearchGate publication ID | 225042242 |
| P2093 | author name string | Adil Baydas | |
| Mehmet Balin | |||
| Ahmet Çelik | |||
| M Ali Kobat | |||
| P2860 | cites work | An endothelial receptor for oxidized low-density lipoprotein | Q24323462 |
| Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor | Q24531178 | ||
| Estrogen receptor transcription and transactivation: Basic aspects of estrogen action | Q24800814 | ||
| Cyclooxygenases regulation by estradiol on endothelium | Q28194799 | ||
| Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q28303699 | ||
| The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
| Assessment and treatment of endothelial dysfunction in humans | Q33731648 | ||
| Sex hormones as potential modulators of vascular function in hypertension | Q34074830 | ||
| Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study | Q34184063 | ||
| Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization | Q34448710 | ||
| Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders | Q34472385 | ||
| Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. | Q34615300 | ||
| Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis | Q34704488 | ||
| Non-genomic actions of sex steroid hormones. | Q35075371 | ||
| Increased risk of atherosclerosis in women after the menopause | Q35708974 | ||
| Role of oxidative stress in coronary heart disease. | Q35891532 | ||
| Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. | Q36093534 | ||
| The forgotten majority: unfinished business in cardiovascular risk reduction | Q36274303 | ||
| Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor | Q36394675 | ||
| Hormones and cardiovascular health in women | Q36522630 | ||
| Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression | Q36793601 | ||
| Systemic effects of smoking | Q36818050 | ||
| A 50-year research journey. From laboratory to clinic | Q37338834 | ||
| Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause? | Q39332677 | ||
| Improvement of function and morphology of tumor necrosis factor-alpha treated endothelial cells with 17-beta estradiol: a preliminary study for a feasible simple model for atherosclerosis | Q39500608 | ||
| Mechanisms of cardioprotection by estrogens | Q41676215 | ||
| Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs | Q43967714 | ||
| Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury | Q44011978 | ||
| Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study | Q44307928 | ||
| A comparison of low-dose and standard-dose oral estrogen on forearm endothelial function in early postmenopausal women | Q44357267 | ||
| Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts | Q44837900 | ||
| Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy | Q45006039 | ||
| Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet | Q45867832 | ||
| Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque | Q46365505 | ||
| Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1). | Q46565716 | ||
| Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture | Q46836594 | ||
| Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein | Q46941848 | ||
| Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage. | Q48016247 | ||
| 17beta-Estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. | Q50944104 | ||
| Menopause is associated with endothelial dysfunction in women. | Q51003976 | ||
| Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. | Q51049618 | ||
| Delivery may affect arterial elasticity in women. | Q51128794 | ||
| Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. | Q54101645 | ||
| Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. | Q54202553 | ||
| Placental estrogen biosynthesis during human pregnancy | Q68384808 | ||
| Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone | Q68610409 | ||
| Effects of gonadectomy and hormonal replacement on rat hearts | Q70034055 | ||
| Estradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants | Q71598016 | ||
| Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women | Q72665668 | ||
| Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease | Q73142316 | ||
| Identification of soluble forms of lectin-like oxidized LDL receptor-1 | Q73536903 | ||
| Impaired ovarian function and risk factors for atherosclerosis in premenopausal women | Q73677521 | ||
| Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability--analysis in hypercholesterolemic rabbits | Q79615711 | ||
| HRT and the young at heart | Q80507203 | ||
| Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? | Q80624716 | ||
| Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits | Q81725115 | ||
| Plasma markers of NO synthase activity in women after ovarian hyperstimulation: influence of estradiol on ADMA | Q83274343 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | human pregnancy | Q11995 |
| reproductive age | Q109745023 | ||
| P304 | page(s) | 837375 | |
| P577 | publication date | 2012-04-26 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Pregnancy followed by delivery may affect circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in women of reproductive age. | |
| P478 | volume | 2012 |
Search more.